Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Furberg

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Controlled Clinical Trials|September 1, 1986
Quality control procedures for the resting electrocardiogram in the Multiple Risk Factor Intervention TrialP M Rautaharju, S K Broste, R J Prineas, et al.
The American Journal of Cardiology|August 15, 1996
Cost-effectiveness of pravastatin in secondary prevention of coronary artery diseaseT Ashraf, J W Hay, B Pitt, et al.
Archives of Internal Medicine|April 24, 1995
Trends in pharmacologic management of hypertension in the United StatesT A Manolio, J A Cutler, C D Furberg, et al.
American Heart Journal|August 5, 2000
Carotid Doppler high-intensity transient signals in dilated cardiomyopathyV A Knappertz, C H Tegeler, C D Furberg, et al.
Circulation|October 12, 2000
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research GroupA A Ariyo, M Haan, C M Tangen, et al.
Circulation|July 1, 1987
Psychological risk factors in coronary artery diseaseP T Costa, D S Krantz, J A Blumenthal, et al.
Circulation|September 27, 2000
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT InvestigatorsB Pitt, R P Byington, C D Furberg, et al.
Lancet (London, England)|December 29, 2000
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trialsM Pahor, B M Psaty, M H Alderman, et al.
Lancet (London, England)|March 7, 2003
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatmentA D Sniderman, C D Furberg, A Keech, et al.
Circulation|November 1, 1993
Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research GroupT A Manolio, C D Furberg, L Shemanski, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Controlled Clinical Trials|September 1, 1986
Quality control procedures for the resting electrocardiogram in the Multiple Risk Factor Intervention TrialP M Rautaharju, S K Broste, R J Prineas, et al.
The American Journal of Cardiology|August 15, 1996
Cost-effectiveness of pravastatin in secondary prevention of coronary artery diseaseT Ashraf, J W Hay, B Pitt, et al.
Archives of Internal Medicine|April 24, 1995
Trends in pharmacologic management of hypertension in the United StatesT A Manolio, J A Cutler, C D Furberg, et al.
American Heart Journal|August 5, 2000
Carotid Doppler high-intensity transient signals in dilated cardiomyopathyV A Knappertz, C H Tegeler, C D Furberg, et al.
Circulation|October 12, 2000
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research GroupA A Ariyo, M Haan, C M Tangen, et al.
Circulation|July 1, 1987
Psychological risk factors in coronary artery diseaseP T Costa, D S Krantz, J A Blumenthal, et al.
Circulation|September 27, 2000
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT InvestigatorsB Pitt, R P Byington, C D Furberg, et al.
Lancet (London, England)|December 29, 2000
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trialsM Pahor, B M Psaty, M H Alderman, et al.
Lancet (London, England)|March 7, 2003
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatmentA D Sniderman, C D Furberg, A Keech, et al.
Circulation|November 1, 1993
Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research GroupT A Manolio, C D Furberg, L Shemanski, et al.
Pageof 21